Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Regulation01:25

Drug Regulation

2.5K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.5K
Pharmacovigilance01:19

Pharmacovigilance

1.4K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

355
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
355
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

85
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
85
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

83
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
83
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

333
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
333

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds.

JAMA·2026
Same author

HHS Says Psychiatric Medications Are Overprescribed, but Are They?

JAMA·2026
Same author

When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up.

JAMA·2026
Same author

Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal.

JAMA·2026
Same author

Under FDA, Unapproved Peptides Likely to Become More Widely Available.

JAMA·2026
Same author

These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?

JAMA·2026

関連する実験動画

Updated: Nov 24, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K

COVID-19 緊急承認について,より透明性が必要です.

Rita Rubin

    JAMA
    |December 22, 2020
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K
    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
    03:53

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

    Published on: November 10, 2023

    1.6K

    関連する実験動画

    Last Updated: Nov 24, 2025

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
    08:41

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

    Published on: November 5, 2021

    3.1K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K
    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
    03:53

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

    Published on: November 10, 2023

    1.6K